JAMA Otolaryngology–Head & Neck Surgery · 2014 · 301 citations · 30 references
MedicineOncologySurgeryOral OncologySurgical OncologySurvival AnalysisCancer StagingCancer Survival AnalysisInvasion In Oral CancerOral Cancer PrognosisOral Cavity CancerTumor StagingConcordance IndexInvasion Depth AssessmentOral Cavity Cancer StagingPrognostic CriteriaPrognostic PredictionTnm Staging SystemTumor Depth Of InvasionTumor Stage Prognosis
IMPORTANCE: The current American Joint Committee on Cancer (AJCC) staging system for oral cancer demonstrates wide prognostic variability within each primary tumor stage and provides suboptimal staging and prognostic information for some patients. OBJECTIVE: To determine if a modified staging system for oral cancer that integrates depth of invasion (DOI) into the T categories improves prognostic performance compared with the current AJCC T staging. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of 3149 patients with oral squamous cell carcinoma treated with curative intent at 11 comprehensive cancer centers worldwide between 1990 and 2011 with surgery ± adjuvant therapy, with a median follow-up of 40 months. MAIN OUTCOMES AND MEASURES: We assessed the impact of DOI on disease-specific and overall survival in multivariable Cox proportional hazard models and investigated for institutional heterogeneity using 2-stage random effects meta-analyses. Candidate staging systems were developed after identification of optimal DOI cutpoints within each AJCC T category using the Akaike information criterion (AIC) and likelihood ratio tests. Staging systems were evaluated using the Harrel concordance index (C-index), AIC, and visual inspection for stratification into distinct prognostic categories, with internal validation using bootstrapping techniques. RESULTS: The mean and median DOI were 12.9 mm and 10.0 mm, respectively. On multivariable analysis, DOI was a significantly associated with disease-specific survival (P < .001), demonstrated no institutional prognostic heterogeneity (I² = 6.3%; P = .38), and resulted in improved model fit compared with T category alone (lower AIC, P < .001). Optimal cutpoints of 5 mm in T1 and 10 mm in T2-4 category disease were used to develop a modified T staging system that was preferred to the AJCC system on the basis of lower AIC, visual inspection of Kaplan-Meier curves, and significant improvement in bootstrapped C-index. CONCLUSIONS AND RELEVANCE: We propose an improved oral cancer T staging system based on incorporation of DOI that should be considered in future versions of the AJCC staging system after external validation.
30
Meta-analysis in clinical trials
Rebecca DerSimonian, Nan M. Laird · Controlled Clinical Trials · 1986 · 39.3K citations
Quantifying heterogeneity in a meta‐analysis
Julian P. T. Higgins, Simon G. Thompson · Statistics in Medicine · 2002 · 36.7K citations
Evaluating the Yield of Medical Tests
Frank E. Harrell · JAMA · 1982 · 3.4K citations
Internal validation of predictive models
Ewout W. Steyerberg, Frank E. Harrell, Gerard Borsboom et al. · Journal of Clinical Epidemiology · 2001 · 2.6K citations